SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-002927 to Assertio Holdings, Inc. (ASRT) (CIK 0001808665) (ASRT)

Assertio Holdings, Inc. (ASRT) (CIK 0001808665)
Date: March 18, 2024 · CIK: 0001808665 · Accession: 0000000000-24-002927

AI Filing Summary & Sentiment

File numbers found in text: 333-277831

Date
March 18, 2024
Author
Not clearly detected
Form
UPLOAD
Company
Assertio Holdings, Inc. (ASRT) (CIK 0001808665)

Letter

United States securities and exchange commission logo March 18, 2024 Heather Mason Chief Executive Officer Assertio Holdings, Inc. 100 South Saunders Road, Suite 300 Lake Forest, IL 60045 Re:Assertio Holdings, Inc. Registration Statement on Form S-3 Filed March 11, 2024 File No. 333-277831 Dear Heather Mason: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Ryan A. Murr, Esq.

Show Raw Text
United States securities and exchange commission logo
March 18, 2024
Heather Mason
Chief Executive Officer
Assertio Holdings, Inc.
100 South Saunders Road, Suite 300
Lake Forest, IL 60045
Re:Assertio Holdings, Inc.
Registration Statement on Form S-3
Filed March 11, 2024
File No. 333-277831
Dear Heather Mason:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Ryan A. Murr, Esq.